CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.89 CNY | +1.45% |
|
-2.83% | -5.62% |
| Apr. 29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
ETFs positioned on Cathay Biotech Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -12.16% | - | |
| 0.81% | 45 M€ | -13.18% | - | |
| 0.81% | 45 M€ | -13.77% | - | |
| 0.81% | 38 M€ | -11.66% | - | |
| 0.00% | 34 M€ | +4.49% | - |
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
2024-08-07
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.62% | 4.17B | |
| +17.56% | 1.84B | |
| -10.14% | 642M | |
| -12.74% | 455M | |
| -81.65% | 216M | |
| -11.25% | 114M | |
| -9.60% | 55.23M |
- Stock Market
- Equities
- 688065 Stock
- Funds and ETFs Cathay Biotech Inc.
